Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma × Sunitinib × Clear all

Phase

Status

Completed 4 Terminated 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 12 Neoplasm Metastasis 5 Kidney Neoplasms 5 Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Glioblastoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Uveal Melanoma 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hormone Refractory Prostate Cancer 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Fatigue 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Carcinoid Tumor 1 Brain Neoplasms 1

Interventions

pembrolizumab 3 anlotinib 3 Paclitaxel 3 Cetuximab 3 sintilimab 2 Sorafenib 2 Radiotherapy 2 Leucovorin 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Docetaxel 2 Cisplatin 2 vistusertib 1 titanium silicide 1 tislelizumab 1 tirbanibulin 1 surufatinib 1 regorafenib 1 poly ICLC 1 pemigatinib 1 olaparib 1 durvalumab 1 donafenib 1 daromun 1 avelumab 1 atezolizumab 1 apatinib 1 advexin 1 Therapeutics 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01216371 2012-02-13

SMAT

Association of Urologic Oncology (AUO)

Phase 2 Unknown

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡